D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 76 Citations 25,459 463 World Ranking 13799 National Ranking 457

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Chemotherapy

The scientist’s investigation covers issues in Internal medicine, Cancer, Colorectal cancer, Surgery and Oncology. His research in Internal medicine intersects with topics in Gastroenterology and Pathology. The various areas that he examines in his Cancer study include Inflammation, Immunology, Quality of life, Disease and Physical therapy.

Stephen Clarke has researched Colorectal cancer in several fields, including Bevacizumab, Rectum and Fluorouracil. His studies in Surgery integrate themes in fields like Clinical trial and FOLFIRI. His Oncology study combines topics from a wide range of disciplines, such as Radiation therapy and FOLFOX.

His most cited work include:

  • Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study (2321 citations)
  • The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer (671 citations)
  • Cancer-related inflammation and treatment effectiveness (646 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Oncology, Cancer, Colorectal cancer and Chemotherapy. His Internal medicine research includes elements of Gastroenterology, Surgery and Pathology. His biological study deals with issues like Retrospective cohort study, which deal with fields such as Univariate analysis.

Stephen Clarke interconnects Quality of life, Immunology, Alternative medicine, Disease and Physical therapy in the investigation of issues within Cancer. His Colorectal cancer research integrates issues from Bevacizumab and Fluorouracil. His research integrates issues of Stage, Regimen, Radiation therapy and Toxicity in his study of Chemotherapy.

He most often published in these fields:

  • Internal medicine (80.08%)
  • Oncology (55.45%)
  • Cancer (35.90%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (80.08%)
  • Oncology (55.45%)
  • Immune system (9.02%)

In recent papers he was focusing on the following fields of study:

Stephen Clarke mainly focuses on Internal medicine, Oncology, Immune system, Cancer research and Cancer. Stephen Clarke regularly ties together related areas like Gastroenterology in his Internal medicine studies. His Oncology study combines topics in areas such as Prospective cohort study, Pancreatic cancer and Chemotherapy.

The concepts of his Immune system study are interwoven with issues in Inflammation, Lymphatic system, Muscularis mucosae and Cytokine. His Cancer research research is multidisciplinary, relying on both Non small cell, Cell, Lung and Immunotherapy. His study looks at the relationship between Colorectal cancer and fields such as Metastasis, as well as how they intersect with chemical problems.

Between 2018 and 2021, his most popular works were:

  • Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis (57 citations)
  • A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers (44 citations)
  • Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study. (36 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Chemotherapy

His primary areas of study are Internal medicine, Immune system, Cancer research, Cytotoxic T cell and Cell. Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Oncology. The study incorporates disciplines such as Microbiome, Colitis and Microbiology in addition to Immune system.

His Cancer research study incorporates themes from Dendritic cell, CD8, Function, Cytotoxic drug and Antigen presentation. His Cytotoxic T cell research incorporates elements of Colorectal cancer, Flow cytometry, Chemotherapy and Mass cytometry. His work deals with themes such as Chemokine, Cytokine and Glioma, which intersect with Cell.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

Leonard B. Saltz;Stephen Clarke;Eduardo Díaz-Rubio;Werner Scheithauer.
Journal of Clinical Oncology (2008)

3641 Citations

Cancer-related inflammation and treatment effectiveness

Connie I Diakos;Kellie A Charles;Donald C McMillan;Stephen J Clarke.
Lancet Oncology (2014)

1312 Citations

The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer

Graeme J.K. Guthrie;Kellie A. Charles;Campbell S.D. Roxburgh;Paul G. Horgan.
Critical Reviews in Oncology Hematology (2013)

1302 Citations

Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer

Jim Cassidy;Stephen Clarke;Eduardo Díaz-Rubio;Werner Scheithauer.
Journal of Clinical Oncology (2008)

1015 Citations

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial

Aimery de Gramont;Eric Van Cutsem;Hans Joachim Schmoll;Josep Tabernero.
Lancet Oncology (2012)

564 Citations

Clinical Pharmacokinetics of Docetaxel

Stephen J. Clarke;Laurent P. Rivory.
Clinical Pharmacokinectics (1999)

547 Citations

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer

W Chua;K A Charles;V E Baracos;S J Clarke;S J Clarke.
British Journal of Cancer (2011)

471 Citations

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

Nico van Zandwijk;Nick Pavlakis;Steven C Kao;Anthony Linton.
Lancet Oncology (2017)

439 Citations

A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.

M J Proctor;D C McMillan;D S Morrison;C D Fletcher.
British Journal of Cancer (2012)

429 Citations

Regulation of Drug Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

Edward T. Morgan;Kerry B. Goralski;Micheline Piquette-Miller;Kenneth W. Renton.
Drug Metabolism and Disposition (2008)

408 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stephen J. Clarke

Donald C. McMillan

Donald C. McMillan

University of Glasgow

Publications: 77

Anthony J. Gill

Anthony J. Gill

University of Sydney

Publications: 48

Josep Tabernero

Josep Tabernero

Vall d´Hebron Institute of Oncology

Publications: 48

Axel Grothey

Axel Grothey

University of Tennessee at Knoxville

Publications: 46

David Cunningham

David Cunningham

Royal Marsden NHS Foundation Trust

Publications: 45

Thierry André

Thierry André

Université Paris Cité

Publications: 45

Leonard Saltz

Leonard Saltz

Memorial Sloan Kettering Cancer Center

Publications: 44

Heinz-Josef Lenz

Heinz-Josef Lenz

University of Southern California

Publications: 41

Alfredo Falcone

Alfredo Falcone

University of Pisa

Publications: 38

Cornelis J. A. Punt

Cornelis J. A. Punt

University of Amsterdam

Publications: 37

Eric Van Cutsem

Eric Van Cutsem

KU Leuven

Publications: 37

Alex Sparreboom

Alex Sparreboom

The Ohio State University

Publications: 36

Richard M. Goldberg

Richard M. Goldberg

West Virginia University

Publications: 36

Hideo Baba

Hideo Baba

Kumamoto University

Publications: 35

Herbert Hurwitz

Herbert Hurwitz

Duke University

Publications: 35

Jos H. Beijnen

Jos H. Beijnen

Antoni van Leeuwenhoek Hospital

Publications: 35

Trending Scientists

Kenneth J. Singleton

Kenneth J. Singleton

Stanford University

Qunwei Wang

Qunwei Wang

Nanjing University of Aeronautics and Astronautics

Bénédicte Cuenot

Bénédicte Cuenot

Centre Européen de Recherche et de Formation Avancée en Calcul Scientifique

Fritz Lipmann

Fritz Lipmann

Harvard University

Peter Skeldon

Peter Skeldon

University of Manchester

Xiyin Wang

Xiyin Wang

North China University of Science and Technology

Mark Yeager

Mark Yeager

University of Virginia

Wilhelm Foissner

Wilhelm Foissner

University of Salzburg

David C. Lye

David C. Lye

Tan Tock Seng Hospital

Hans Puxbaum

Hans Puxbaum

TU Wien

Mats Holmström

Mats Holmström

Swedish Institute of Space Physics

Coleen L. Moloney

Coleen L. Moloney

University of Cape Town

Petra Gastmeier

Petra Gastmeier

Charité - University Medicine Berlin

Henri Wallaschofski

Henri Wallaschofski

Greifswald University Hospital

Something went wrong. Please try again later.